| 2011 |
ER/ES(電磁的記録/電子署名)通知への対応がなぜ必要なのか?, Clinical Research Proffeionals No.25 (8) |
| 2010 |
医薬品開発におけるIT化の方向性;臨床医薬, 26(4) : 261-272 |
| 2009 |
医療情報の電子化と治験のIT化 3
製薬企業における電子化・IT化の取り組みと今後の展望, Clinical Research Proffeionals No.12 (6) , 50-59. |
| 2009 |
医薬品規制情報の伝達に関する電子的標準に関するトピックの動向 M2(eCTD):緊急安全性情報等の電子媒体による伝達/電子化申請様式; 医薬品研究Vol.40 (10), 670-672 |
2006
|
平成17年度治験推進研究事業研究報告書 − 治験IT 化の現状と課題 「治験 IT 化の現状と課題(PDFファイル)」(研究協力者) |
| 2005 |
平成16年度厚生労働科学特別研究事業「次世代医療機器研究・開発・商業化
促進のための薬事承認の在り方に関する研究治験の電子化に関する調査研究」「治験電子化に関する調査研究班(PDFファイル)」(研究協力者) |
| 1997 |
Effect of water content and temperature on the stability of lornoxicam tablets: Drug Stability, 4, 202-208 |
| 1996 |
Degradation products and pathway of lornoxicam in aqueous solution: Drug Stability, 1, 166-172 |
| 1996 |
Increasing of sensitivity by Acetylating derivatization on High-Performance Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass: Bunseki Kagaku, 45(6)(日本分析化学会), 501-504 |
1995
|
Improvement of dissolution characteristics of 4-t-butyl-2’carboxymethoxy-4’-(3-methyl-2-butenoyloxy) chalcone by b-cyclodextrin complex: Eur. J. Pharm. Sci, 3, 323-328 |
| 1995 |
Improvement of Dissolution Characteristics of New Chalcone Derivative, SU-740:Comparison between Size Reduction, Solid Dispersion and Inclusion Complexation: Chem. Pharm. Bull, 43(12), 2221-225 |
| 1995 |
Method of increasing sensitivity of liquid chromatography-atmospheric pressure chemical ionization mass spectrometry using a semi-micro column: J. Chrom. A, 715, 13-18 |
| 1995 |
Degradation kinetics of KE-298 and chelating ability of its degradation products: Int. J. Pharm., 124, 129-135 |
| 1994 |
Determination of Vitamin D3 and D2 in Multi-Vitamin tablets by High-Performance Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry: Anal. Sci., 10, 457-460 |
1994
|
Determination of Prostaglandins by High-Performance Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry: Bunseki Kagaku, 43, 189-194 |